Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate. Nicholas J A, Boster A L, Imitola J, O'Connell C, Racke M K Drug Des Devel Ther. 2014; 8:897-908. Epub 2014 Jul 07. PMID: 25045248. Abstract CommentRecommendBookmarkWatch